Nine Monthly Results Results Snapshot
Figures in Cr
Consolidate Nine Monthly Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
2,094.83
1,914.39
1,617.40
1,366.16
1,072.79
1,045.98
789.08
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
2,094.83
1,914.39
1,617.40
1,366.16
1,072.79
1,045.98
789.08
Raw Material Cost
694.23
564.95
519.32
500.77
416.62
321.09
225.93
Purchase of Finished goods
304.68
413.51
281.31
152.39
59.82
162.85
113.89
(Increase) / Decrease In Stocks
-112.29
-159.94
-32.33
24.37
28.77
-39.24
57.26
Employee Cost
314.18
253.08
213.90
178.48
159.94
134.44
122.24
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
-0.02
0.00
0.00
-0.02
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
488.66
428.78
286.27
280.40
212.40
222.61
-293.71
Total Expenditure (Excl Depreciation)
1,689.46
1,500.38
1,268.47
1,136.39
877.55
801.75
225.59
Operating Profit (PBDIT) excl Other Income
405.37
414.01
348.93
229.77
195.24
244.23
563.49
Other Income
47.35
42.73
33.89
48.30
26.51
0.68
10.09
Operating Profit (PBDIT)
452.72
456.74
382.82
278.07
221.75
244.91
573.58
Interest
17.82
8.23
6.36
6.69
3.42
5.16
6.71
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
434.90
448.51
376.46
271.38
218.33
239.75
566.87
Depreciation
74.35
60.64
53.21
37.91
23.42
34.82
17.04
Profit Before Tax
360.55
387.88
323.25
233.48
194.91
204.94
99.61
Tax
89.52
95.98
86.00
50.87
37.75
45.90
21.60
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
271.03
291.90
237.26
182.62
157.16
159.04
78.01
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
271.03
291.90
237.26
182.62
157.16
159.04
78.01
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-0.28
-0.86
-2.38
-0.44
-1.55
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
269.77
290.03
235.42
184.38
155.61
159.04
78.01
Equity Capital
45.32
45.32
45.32
40.30
40.93
40.93
40.93
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Diluted Earnings per share
2.5
2.31
1.84
1.56
1.2
1.42
0.71
Operating Profit Margin (Excl OI)
19.35%
21.63%
21.57%
16.82%
18.2%
23.35%
71.41%
Gross Profit Margin
20.76%
23.43%
23.28%
19.86%
20.35%
22.92%
71.84%
PAT Margin
12.94%
15.25%
14.67%
13.37%
14.65%
15.2%
9.89%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Nine Monthly Analysis Highlights
Net Sales
YoY Growth in nine months ended Dec 2025 is 9.43% vs 18.36% in Dec 2024
Consolidate Net Profit
YoY Growth in nine months ended Dec 2025 is -6.99% vs 23.20% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in nine months ended Dec 2025 is -2.09% vs 18.65% in Dec 2024
Interest
YoY Growth in nine months ended Dec 2025 is 116.52% vs 29.40% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in nine months ended Dec 2025 has fallen from Dec 2024
Compare Nine Monthly Results Of Marksans Pharma With
Figures in Cr
Consolidate Nine Monthly Results
Change(INR)
Change(%)
Net Sales
2,094.83
0
2,094.83
Other Operating Income
0.00
0.00
0.00
Total Operating income
2,094.83
0
2,094.83
Raw Material Cost
694.23
0
694.23
Purchase of Finished goods
304.68
0
304.68
(Increase) / Decrease In Stocks
-112.29
0
-112.29
Employee Cost
314.18
0
314.18
Power Cost
0.00
0
0.00
Manufacturing Expenses
0.00
0
0.00
Selling and Distribution Expenses
0.00
0
0.00
Other Expenses
488.66
0.00
488.66
Total Expenditure (Excl Depreciation)
1,689.46
0
1,689.46
Operating Profit (PBDIT) excl Other Income
405.37
0.00
405.37
Other Income
47.35
0
47.35
Operating Profit (PBDIT)
452.72
0
452.72
Interest
17.82
0
17.82
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
434.90
0
434.90
Depreciation
74.35
0
74.35
Profit Before Tax
360.55
0
360.55
Tax
89.52
0
89.52
Provisions and contingencies
0.00
0
0.00
Profit After Tax
271.03
0
271.03
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0.00
0
0.00
Other Adjustments
0.00
0
0.00
Net Profit
271.03
0
271.03
Share in Profit of Associates
0.00
0
0.00
Minority Interest
-0.28
0
-0.28
Other related items
0.00
0.00
0.00
Consolidated Net Profit
269.77
0
269.77
Equity Capital
45.32
0
45.32
Face Value
1.00
0
0.00
Reserves
0.00
0
0.00
Gross Profit Margin
20.76%
0%
0.00
20.76%
PAT Margin
12.94%
0%
0.00
12.94%
Public Share Holdings (%)
0.00%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0%
0.00
0.00%
Nine Monthly - Net Sales
Net Sales 2,094.83 Cr
in Dec 2025Figures in Cr
YoY Growth in nine months ended Dec 2025 is 9.43% vs 18.36% in Dec 2024
Nine Monthly - Consolidate Net Profit
Consolidate Net Profit 269.77 Cr
in Dec 2025Figures in Cr
YoY Growth in nine months ended Dec 2025 is -6.99% vs 23.20% in Dec 2024
Nine Monthly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 405.37 Cr
in Dec 2025Figures in Cr
YoY Growth in nine months ended Dec 2025 is -2.09% vs 18.65% in Dec 2024
Nine Monthly - Interest
Interest 17.82 Cr
in Dec 2025Figures in Cr
YoY Growth in nine months ended Dec 2025 is 116.52% vs 29.40% in Dec 2024
Nine Monthly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 19.35%
in Dec 2025Figures in %
YoY Growth in nine months ended Dec 2025 has fallen from Dec 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
